Zhejiang Wecome Pharmaceutical Company Limited (SHE:300878)

China flag China · Delayed Price · Currency is CNY
32.13
-1.03 (-3.11%)
Jan 23, 2026, 3:04 PM CST
131.65%
Market Cap4.56B
Revenue (ttm)131.67M
Net Income (ttm)-315.38M
Shares Out142.05M
EPS (ttm)-2.20
PE Ration/a
Forward PEn/a
Dividend0.14 (0.42%)
Ex-Dividend Daten/a
Volume6,825,376
Average Volume5,291,399
Open32.25
Previous Close33.16
Day's Range31.18 - 34.40
52-Week Range13.08 - 37.11
Beta0.39
RSI60.50
Earnings DateApr 29, 2026

About SHE:300878

Zhejiang Wecome Pharmaceutical Company Limited engages in the research and development, production, and sale of modern traditional Chinese and western medicine in China. The company offers products in various forms, including hard capsules, tablets, granules, soft capsules, pills, and other dosage forms. It also operates the retail of pharmaceutical commercial products. The company was formerly known as Zhejiang Weikang Pharmaceutical Co., Ltd. Zhejiang Wecome Pharmaceutical Company Limited was founded in 2000 and is based in Lishui, China. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2000
Employees 650
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 300878
Full Company Profile

Financial Performance

In 2024, SHE:300878's revenue was 351.20 million, a decrease of -32.41% compared to the previous year's 519.62 million. Losses were -147.43 million, 1546.4% more than in 2023.

Financial Statements